ABSTRACT-Acute cerebral ischemia was produced in rats by injection of arachidonic acid (AA) into the internal carotid artery. Evans blue (EB) was intravenously injected and its extravasation into the brain was determined as an indicator of disturbances in the blood-brain barrier and endothelial cells. Control animals showed severe cerebral edema and marked blue staining of the brain. Benidipine (30 ,ug/kg, i.p.) suppressed the increase in cerebral water content and the extravasation of EB. Similarly, nicardipine (100,ug/kg, i.p.) suppressed the elevation of water content and the extravasation of EB. Furthermore, both benidipine (30,ug/kg, i.p.) and nicardipine (100,ug/kg, i.p.) improved, the neuronal injuries following AA-injection. An antiplatelet agent, ticlopidine (100 mg/kg, i.p.), and a thrombox ane A2 synthetase inhibitor, OKY-1581 (3 mg/kg, i.p.), also suppressed the elevation of cerebral water content. A lipoxygenase inhibitor, AA-861 (200 mg/kg, p.o.), and a cyclooxygenase inhibitor, in domethacin (10 mg/kg, i.p.), did not prevent the increase in cerebral water content. Neither benidipine (3-30pg/kg, i.v.) nor nicardipine (100,ug/kg, i.v.) inhibited the AgNO3-induced thrombus formation of the abdominal aorta, whereas ticlopidine (100 mg/kg, p.o.) and OKY-1581 (3 mg/kg, i.v.) prevented the thrombus formation. From the present results, it is suggested that benidipine, as well as nicardi pine, may protect against AA-induced acute cerebral infarction via a mechanism independent of anti thrombotic action.
It has recently been reported that calcium antagonists have ameliorating effects on cerebral damages in va rious animal models of acute cerebral ischemia (1 4) . Clinically, nicardipine and nimodipine have been re ported to be beneficial in patients with subarachnoid hemorrhage and to reduce the ischemic damage result ing from reduction of cerebral blood flow (5) . Arachi donic acid (AA) is one of the polyunsaturated fatty acids which are present in membrane phospholipids. It is a potent stimulator of platelet aggregation and is known to induce endothelial damage and edema in the brain (6) (7) (8) (9) . Thus, the cerebral infarction induced by the infusion of AA into the internal carotid artery has been used as an experimental thrombo-embolic stroke model. However, the morphological changes and the mechanisms involved have not been fully clarified in the AA-induced cerebral infarction.
It has been reported that antiplatelet agents have ameliorating effects on AA-induced cerebral damage in rabbits (10, 11) . In contrast, there are few reports con cerning the effect of calcium antagonists on AA-in duced cerebral damage (12) . Benidipine is a newly-de veloped 1,4-dihydropyridine calcium antagonist (13) that has long-lasting antihypertensive and antianginal activities (14, 15) . In the present study, we investigated the possible protective effects of benidipine on AA-in duced acute cerebral infarction in rats, and also ex amined whether platelet aggregation is related to the pathogenesis of cerebral infarction induced by AA.
MATERIALS AND METHODS

Animals
Male Wistar rats, weighing 250 300 g, were used for the experiment. Prior to the experiment, all animals had free access to standard rat chow and water.
AA-induced cerebral infarction Rats were anesthetized by an intraperitoneal injec tion of sodium pentobarbital at 50 mg/kg. A polyethylene cannula was inserted from the right exter nal carotid artery to the origin of the internal carotid artery. At a fixed time after the treatment with a test compound, 0.5 mg/kg of AA was injected rapidly through the cannula. Ca-antagonists such as benidipine and nicardipine, OKY-1581 or indomethacin were peri toneally injected at 30 min before the injection of AA. AA-861 and ticlopidine were orally administered at 2 and 4 hr before the injection of AA, respectively.
Cerebral water content
Three hours after the injection of AA, the animal was sacrificed by decapitation. The whole brain was re moved from the skull, and the wet weight (W) of the left and right cerebral hemisphere was measured. Both cerebral hemispheres were then dried in an oven heated at 90°C for 3 days and then weighed again to obtain the dry weight (D). The cerebral water content was calcu lated as follows:
Extravasation of EB
In some experiments, 5 min after the AA-injection, Evans blue (EB) (2% in saline, 0.1 ml per 100 g body weight) was injected intravenously. Three hours after the injection of AA, the animal was sacrificed. The whole brain was removed from the skull, and the wet weight (W) of the left and right cerebral hemisphere was measured. Each cerebral hemisphere was dissolved in 5 ml of 1 N KOH, to which 9 ml of phosphoric acid acetone mixture was added, mixed and centrifuged at 1000 X g for 10 min to extract the dye. The absorbance of the supernatant was determined at the wavelength of 620 nm using a spectrophotometer, and the amount of dye-leakage was determined from a previously prepared calibration curve.
In another series of experiments, the extravasation of EB was determined in rats not injected with AA, in order to examine the effects of AA and the drug per se.
Histological examination
For histologic analysis, 6 to 13 rats of each group were prepared. Thirty minutes after the administration of benidipine (30,ug/kg, i.p.) and nicardipine (100 pg/kg, i.p.), AA was injected intravenously. Three hours after the injection of AA, the cerebrum of each rat was removed and fixed in buffered 10% formal dehyde (pH 7.25). The cerebrum was cut coronally into 2 3 mm slices including the corpus mamill, and then each slice was embedded in paraffin using a standard technique. The paraffin sections were stained with hematoxylin and eosin to determine the quality and ex tent of cerebral lesions. Cerebral lesions were assessed using the following grading criteria: +, focal and mild changes; + +, more extensive but not diffuse and mod erate changes; + + +, diffuse and moderate changes; + + + +, diffuse and severe changes.
Experimental thrombosis in rats
Thrombus was produced in rats by a slight modifica tion of the method described by Zimmermann et al. (16) . Under sodium pentobarbital (50 mg/kg, i.p.) anesthesia, the abdominal aorta and jugular vein were carefully cleared of surrounding connective tissues. The jugular vein and femoral artery were cannulated for in jection of either vehicle or drug and for recording fem oral arterial blood pressure, respectively. Vessel wall le sions were induced by perivascular application of a solution of 30% silver nitrate (AgNO3) for 4 min. For standardization, the vessel was kept in a plastic grove (10-mm length). The injury to the vessel wall was stop ped by washing out the artery with saline. The thrombotic occlusion of the abdominal aorta decreased the blood pressure of the femoral artery almost to 0 mmHg. Test compounds, except for ticlopidine, were intravenously injected 5 min before exposing the artery to AgNO3. Ticlopidine was orally administered 4 hr be fore exposing the artery to AgNO3.
Drugs
Benidipine (hydrochloride, KW-3049), nicardipine (hydrochloride), OKY-1581 (17), a thromboxane A2 synthetase inhibitor (TXSI) and AA-861 (18), a 5 lipoxygenase inhibitor, were synthetized in our labor atories. Indomethacin and AA (sodium salt) were purchased from Sigma Chemical Co. Ticlopidine was purchased from Ricerchimica. Benidipine and nicardi pine were dissolved in saline containing 5% Tween-80, and OKY-1581 and indomethacin were dissolved in 0.05 N NaOH-saline. The stock drug solutions were then diluted with saline for intravenous or intraperi toneal administrations, so that the injection volume would be 0.1 ml solution per 100 g of animal's body weight. For oral administration, ticlopidine and AA-861 were suspended in 0.3% carboxymethyl cellulose solu tion so that the administration volume would be 1 ml suspension per 100 g of animal's body weight. Since in domethacin at a dose of 2 mg/kg (i.v.) is reported to inhibit platelet aggregation ex vivo (19) , a dose of 10 mg/kg (i.v. or i.p.) was used in this experiment. Table 1 . Effects of benidipine and nicardipine on cerebral water content 3 hr after the injec tion of arachidonic acid Table 2 . Effects of various drugs on cerebral water content 3 hr after the injection of arachi donic acid
RESULTS
Brain water content Time course of the elevation of water content in the right hemisphere following AA-injection is shown in Fig. 1 . The cerebral water content gradually increased with time after AA-injection, and the peak response was attained after 4 to 6 hours. Benidipine (30pg/kg, i.p.) inhibited the increase in cerebral water content, the effect being statistically significant (Table 1) . Simi larly, nicardipine (100,ug/kg, i.p.) had an ameliorating effect on the increase in cerebral water content. Ticlo pidine (100 mg/kg, p.o.) and OKY-1581 (3 mg/kg, i.p.) also inhibited the elevation of cerebral water content (Table 2 ). In contrast, the cyclooxygenase inhibitor in domethacin (10 mg/kg, i.p.) and the lipoxygenase in hibitor AA-861 (200 mg/kg, p.o.) had no effect on the increase in cerebral water content.
Effects on extravasation of EB When AA was not injected, the extravasations of EB were 0.40 ± 0.07 ,u g/brain, 0.38 ± 0.11 Pg/brain and 0.37 ± 0.05 pg/brain in the vehicle-, nicardipine (300 pg/kg, i.p.) and benidipine (100 /-cg/kg, i.p.)-treated groups, respectively. These values were not significantly different among these three groups and were very low compared with that of the control group injected with AA (56.31 ± 2.79,ug/brain).
Benidipine (3 100,ug/kg, i.p.) decreased the extra vasation of EB following AA-injection in a dose-de pendent manner. The inhibitory effects of benidipine were statistically significant at doses of 10,ug/kg and greater. While nicardipine at a dose of 100,ug/kg pre vented the extravasation of EB, 300,ug/kg of it did not (Fig. 2) . The protective potency of benidipine of AA induced extravasation of EB was approximately 3 times higher than that of nicardipine. Ticlopidine (100 mg/kg, p.o.) and OKY-1581 (3 mg/kg, i.p.) also inhibited the extravasation of EB (data not shown).
Histological examination
Three hours after the injection of AA, the neuronal neurons were observed in the cerebral cortex, hippo campus, thalamus and hypothalamus. The lesions in cluded congestion of vessels, perivascular edema, ex travasated hemorrhage, edematous and spongiose neuropil, and cell shrinkage or karyopyknosis of neurons. Some lesions were observed even in the neocortex of the hemisphere contrarateral to that in jected with AA. The benidipine (30,ug/kg, i.p.)-treated group exhibited less neuronal injury compared with the control group (Figs. 3 and 4) . The treatment with nicar dipine (100 ,u g/kg, i) p.) also ameliorated the lesions similarly to that with benidipine (Table 3) .
Effects on AgNO3-induced thrombus formation
Within 60 min following AgNO3-application, the abdominal aorta was almost completely filled with thrombi and the fall of femoral arterial blood pressure was detected in all rats of the control group. As shown in Table 4 , neither benidipine (10, 30,ug/kg, i.v.) nor nicardipine (100,ug/kg, i.v.) inhibited the thrombus formation in the abdominal aorta. While ticlopidine (100 mg/kg, p.o.) and OKY-1581 (3 mg/kg, i.v.) pre vented the thrombus formation, indomethacin (10 mg/kg, i.v.) did not. Fig. 2 . Effects of benidipine and nicrdipine on extravasation of EB 3 hr after the injection of AA in rats. The drugs were administered 30 min before the injection of AA. Column heights represent the mean values ± S.E.M of 6 rats. *and* *. significantly different from the control at P < 0.05 and P < 0.01, respectively.
DISCUSSION
AA is a potent inducer of platelet aggregation and has been demonstrated to produce cerebral infarction in rabbits and rats when injected into the carotid artery (6) (7) (8) 20) . There have been several reports indicating that antiplatelet agents exert beneficial effects in this model (10, 11, 21) . The interesting finding of the pres ent study is that the Ca-antagonist benidipine, which did not show any antithrombotic effects, exhibited be neficial effects of AA-induced cerebral infarction. Therefore, the mechanism for the protective effects of benidipine on AA-induced cerebral infarction seems to be different from those of an antiplatelet agent like tic lopidine.
In our preliminary electronic microscopic study, in travascular platelet thrombus formation associated with pronounced cerebral damage was observed in some areas of the brain injected with AA. Moreover, ticlopi dine (100 mg/kg, p.o.), known as an antiplatelet drug (22) , not only prevented the formation of arterial thrombus induced by AgNO3 but also reduced the cere bral damage induced by the injection of AA. There fore, it seems that platelet aggregation is one of the im portant deleterious factors responsible for vascular in juries in AA-induced cerebral damage and that the pro tective action of ticlopidine is mediated via its anti platelet effect. In AA-induced cerebral infarction, vascular per meability increasing factors originating from activated platelets such as serotonin and thromboxane A2 may be important (23) . OKY-1581 inhibited AgNO3-induced thrombus formation in the abdominal aorta in a dose dependent manner, and the effect of a dose of 3 mg/kg (i.p.) was statistically significant. Additionally, OKY 1581 (3 mg/kg, i.p.) prevented the extravasation of EB as well as the increase in cerebral water content. The present results are in agreement with the previous re port (21) that OKY-046, a TXSI, ameliorates the AA induced cerebral infarction in rats. These findings sug gest that thromboxane A2 may be involved in the eleva tion of vascular permeability as well as the thrombus formation, both of which could finally lead to cerebral damage. However, the cyclooxygenase inhibitor in domethacin (10 mg/kg, i.p.) did not suppress the in crease in cerebral water content induced by injection of AA. Indomethacin inhibits the formation of both thromboxane A2 and PGI2, the latter of which is in volved in so called cytoprotection or membrane stabi lization (24) (25) (26) . Therefore, the reduction of PGI2 seems to be the reason for the inability of indomethacin to prevent cerebral infarction.
Minamisawa et al. (27) reported that the lipoxygen ase inhibitor AA-861 (200 mg/kg, p.o.) suppressed the increase in water content in a rat model of transient ischemia with reperfusion and suggested that the in crease in leukotriene C4 levels was causally related to the increase in cerebral water content. In addition, De mpsey et al. (28) reported that the lipoxygenase inhibi for nordihydroguaeretic acid limited the formation of ischemic cerebral edema. In the present study, howev er, AA-861 (200 mg/kg, p.o.) failed to protect against the increase in cerebral water content induced by the injection of AA. It is not likely, therefore, that the metabolites of the 5-lipoxygenase pathway play a major role in the elevation of water content in the present model of AA-induced cerebral infarction. The Ca-antagonists benidipine and nicardipine did not suppress the AgNO3-induced thrombus formation in abdominal aorta, indicating that these drugs do not have substantial antiplatelet or antithrombotic effects in rats in vivo. Moreover, our unpublished observation in dicates that benidipine does not inhibit platelet aggrega tion induced by collagen in vitro in rats. Nevertheless, both drugs exhibited the beneficial effects on AA-in duced cerebral infarction. These findings suggest that the protective mechanism of benidipine and nicardipine is different from those of antiplatelet drugs.
In our present study, while 100,ug/kg (i.p.) of nicar dipine significantly ameliorated the extravasation of EB, 300,ug/kg (i.p.) was ineffective. An excessive re duction of blood pressure can induce a decrease in cerebral blood flow and finally promote carebral ische mia in damaged brain. Thus, the deleterious effect of nicardipine at the high dose of 300,ug/kg seems to be due to the excessive reduction (about 50 mmHg) of blood pressure. Hladovec and DeClerck (29) previously showed that calcium antagonists inhibit endothelial cell injury in rats subjected to perturbations of plasma Ca balance in vivo. Recently, Karasawa et al. (30) have demonstrated that benidipine protects against endothelial cell damage resulting from ischemia and reperfusion. These observa tions raise the possibility that the protective action of benidipine against AA-induced cerebral infarction might be due to the protection against the endothelial cell damage. This hypothesis seems to be supported by the fact that benidipine prevented the extravasation of EB, an indicator of a disturbance in the blood brain barrier (31, 32) , which is formed by the endothelial lin ings of cerebral vasculatures.
Fujimoto et al. (8) recently reported that when AA was injected into the cerebral artery, marked vascular injuries were observed even in the absence of circulat ing platelets. The authors suggested that the cerebral vascular injuries induced by AA may not always be due to the platelet aggregation. In our electron microscopic studies of the cerebrum of rats injected with AA, en dothelial denudation of small vessels and perivascular edematous changes were observed even without mural platelet thrombi. In some cases, deendothelialization was observed in accord with thrombus formation (data not shown). Since AA is known to have a detergent effect (8, 33) , the vascular injuries induced by AA may be caused, at least partly, by this effect. Endothelial cell damage produced by the detergent effect of AA could, in turn, induce platelet adhesion and accelerate the permeability of venules within the brain tissues (8) , resulting in more exagerated cerebral injuries like ede ma. Thus, AA could induce endothelial damage either by its detergent effect or by its platelet aggregatory effect, leading to the formation of thromboxane A2. In any case, calcium antagonists seem to have protective effects against endothelial cell damage, although the mechanism involved is not fully understood.
Another possible explanation for the protection by benidipine is that Ca-overload into brain cells was inhi bited by benidipine. A rise in cytosolic free calcium has been postulated to be an important cause of irreversible cell injury in ischemia (34, 35) . Recently, benidipine has been reported to have beneficial effects in ischemic organ failures of diverse origins (36, 37) . Therefore, be nidipine might protect against the progression of cere bral injury following the obstruction of cerebral vascul ature. The present results also suggest that benidipine may have some beneficial effects on cerebral infarction.
